Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PhamAsia News Top Editors' Picks Of 2010

06 Jan 2011

• By PharmAsia News

Related Content

Pfizer, Merck Execs Share Emerging Markets Strategies - Windhover's Pharmaceutical Strategic Alliances Conference (Part 2 of 2)

05 Oct 2010

Stage Set For India To Frame Compulsory Licensing Provisions As Contrasting Groups Make Their Case

04 Oct 2010

Takeda Shows Signs Of Undergoing Corporate Shift In Decision-making

30 Nov 2010

Egyptian Price Reform Ruling Soon; What's Next For MNC Drug Makers?

22 Nov 2010

WuXi PharmaTech Rebounds; Prepares For A Surge In China Biologics

17 Nov 2010

Korea's Celltrion Eyes Eastern Bloc For Biosimilar Expansion

05 Nov 2010

Patent Cliff Leads Pfizer To Begin Direct Sales To Pharmacies; Aussie Distributors Reeling

15 Dec 2010

China Signals Need For Private Investment To Support Its Healthcare Reforms; Private Insurance Options Likely To Widen

16 Dec 2010

PMDA Cuts Review Lag With West In Half, But Application Lag Shows No Relief For Drug Launches In Japan

11 Nov 2010

Pfizer, Biocon Brush Off Deal Talks As Speculative, But Is There Fire Behind The Smoke?

03 Sep 2010

Green Cross To Focus On Biobetters As Korean Biosimilar Space Gets Crowded: Bio Korea Conference

02 Sep 2010

U.S. FDA China Country Head Chris Hickey On FDA's Mission In China: An Interview With PharmAsia News (Part 2 of 2)

02 Sep 2010

Abbott, Baxter, Bristol-Myers Squibb: Emerging Markets Earnings Roundup (Part 1 of 3)

02 Aug 2010

AstraZeneca, GlaxoSmithKline, Merck: Emerging Markets Earnings Roundup (Part 2 of 3)

06 Aug 2010

Pfizer, Sanofi-Aventis, Eli Lilly: Emerging Markets Earnings Roundup (Part 3 of 3)

11 Aug 2010

Medicines Australia Negotiates Lower Off-patent Prices In Exchange For Level Prices For Innovative New Drugs In Newly Announced Federal Budget

13 May 2010

Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical

24 May 2010

Pfizer Returns To Japan To Identify Technology And Compound Targets

05 Jul 2010

Japan To Experiment With New NHI Drug Pricing Policy In FY 2010

13 Jan 2010

New Pricing System Could Deal A Blow To South Korea's Generic-Dependent Companies

19 Feb 2010

Korea's Anti-Rebate Laws Seen Sparking More Demand For MNC Products

03 May 2010

GSK's Sandy Macrae On R&D For Emerging Markets: An Interview With PharmAsia News (Part 2 of 2)

28 Jun 2010

Philippine Drug Price Controls Pinch Brands And Generics

25 Jun 2010

China's New Guideline For Drug Pricing Favors Innovation And First-to-market Generics

14 Jun 2010

Eli Lilly CEO John Lechleiter Rules Out Mega-merger Or Major Push Into Generics, Outlines Strategy Aimed At China's 21st Century Rise In An Interview With PharmAsia News

22 Apr 2010

Taiwan's Biotech Sector Plan Stalled By Funding Limitations, Wary Investors

16 Aug 2010

Indian Firms Must Be In Indian Hands, Says Government Paper; Highlights Threats to Compulsory Licensing And Drug Pricing

25 Aug 2010

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.